Innospec Inc.
IOSP
$100.62
$1.081.09%
| Weiss Ratings | IOSP - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Weak | |||
| Risk Grade | D+ | |||
| Reward Grade | C+ | |||
| Rating Factors | IOSP - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Good | |||
| Growth Index | Weak | |||
| Efficiency Index | Good | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Fair | |||
| Beta / Standard Deviation | IOSP - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.96 | |||
| Price History | IOSP - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -3.26% | |||
| 30-Day Total Return | -12.07% | |||
| 60-Day Total Return | -13.68% | |||
| 90-Day Total Return | -7.90% | |||
| Year to Date Total Return | -6.52% | |||
| 1-Year Total Return | -20.38% | |||
| 2-Year Total Return | -5.56% | |||
| 3-Year Total Return | 12.26% | |||
| 5-Year Total Return | 47.46% | |||
| 52-Week High % Change | -24.74% | |||
| 52-Week Low % Change | 3.59% | |||
| Price | IOSP - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $133.71 | |||
| 52-Week Low Price | $97.13 | |||
| 52-Week Low Price (Date) | Mar 05, 2025 | |||
| 52-Week High Price (Date) | May 10, 2024 | |||
| Valuation | IOSP - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 2.51B | |||
| Enterprise Value | 2.27B | |||
| Price/Earnings (TTM) | 71.96 | |||
| Earnings Per Share (TTM) | 1.40 | |||
| Earnings Per Share Growth | -74.91% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 1.36 | |||
| Price/Book (Q) | 2.07 | |||
| Enterprise Value/Revenue (TTM) | 1.23 | |||
| Price | $100.62 | |||
| Enterprise Value/EBITDA (TTM) | 29.97 | |||
| Enterprise Value/EBIT | 69.48 | |||
| Market Cap Category | Mid Cap | |||
| Dividends and Shares | IOSP - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 24.95M | |||
| Dividend Yield | 1.54% | |||
| Div. Per Share (Most Recent) | $0.79 | |||
| Dividend Per Share (TTM) | $1.55 | |||
| Payout Ratio (TTM) | 108.99% | |||
| Dividend Per Share (Most Recent) | $0.79 | |||
| Company Info | IOSP - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 303 792 5554 | |||
| Address | 8310 South Valley Highway Englewood, CO 80112 | |||
| Website | innospec.com | |||
| Country | United States | |||
| Year Founded | 1938 | |||
| Profitability | IOSP - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 1.77% | |||
| Profit Margin | 1.92% | |||
| Management Effectiveness | IOSP - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 1.19% | |||
| Return on Equity | 3.01% | |||
| Income Statement | IOSP - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 1.85B | |||
| Total Revenue (TTM) | 1.85B | |||
| Revenue Per Share | $73.97 | |||
| Gross Profit (TTM) | 542.90M | |||
| EBITDA (TTM) | 75.80M | |||
| EBIT (TTM) | 32.70M | |||
| Net Income (TTM) | 35.60M | |||
| Net Income Avl. to Common (TTM) | 35.60M | |||
| Total Revenue Growth (Q YOY) | -5.64% | |||
| Earnings Growth (Q YOY) | -286.24% | |||
| EPS Diluted (TTM) | 1.40 | |||
| EPS Diluted Growth (Q YOY) | -286.49% | |||
| Balance Sheet | IOSP - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 289.20M | |||
| Cash Per Share (Q) | $11.59 | |||
| Total Current Assets (Q) | 956.60M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 1.22B | |||
| Current Ratio (Q) | 2.576 | |||
| Book Value Per Share (Q) | $48.53 | |||
| Total Assets (Q) | 1.73B | |||
| Total Current Liabilities (Q) | 371.40M | |||
| Total Debt (Q) | 44.90M | |||
| Total Liabilities (Q) | 518.60M | |||
| Total Common Equity (Q) | 1.21B | |||
| Cash Flow | IOSP - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -62.00M | |||
| Cash from Financing (TTM) | -35.30M | |||
| Net Change in Cash (TTM) | 85.50M | |||
| Levered Free Cash Flow (TTM) | 30.84M | |||
| Cash from Operations (TTM) | 184.50M | |||
